3003新葡的京集团
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.02.17
关于2015年度日常关联交易预计的公告
2015.01.28
关于子公司医疗器械产品完成欧盟注册的公告
2015.01.15
关于子公司医疗器械产品完成欧盟注册的公告
2014.12.12
关于公司使用自有资金购买低风险理财产品的进展公告
2014.12.03
关于公司使用自有资金对TPG BIOTECHNOLOGY PARTNERS IV, L.P.进行投资的进展公告
2014.12.03
关于公司使用自有资金购买低风险理财产品的进展公告
2014.11.26
关于全资子公司使用自有资金对CANTEX进行投资的进展公告
2014.11.21
关于全资子公司使用自有资金对CANTEX进行投资的公告
2014.11.21
第三届董事会第六次会议决议公告
2014.11.20
2014年第四次临时股东大会决议公告
第一页
上一页
106
107
108
109
110
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.